School of Allied Health Professions, LSU Health Sciences Center, Shreveport, LA 71130-3932, USA.
Pathobiology. 2009;76(6):322-8. doi: 10.1159/000245898. Epub 2009 Nov 30.
Whether changes in the hyaluronan moiety of synovial fluid are associated with osteoarthritis (OA) is unresolved experimentally, notwithstanding frequent statements in the literature that the disease leads to degraded hyaluronan. We evaluated this hypothesis by comparing the molecular weight and concentration of hyaluronan in synovial fluid from patients with and without OA.
Synovial fluid was obtained by needle aspiration from patients with advanced OA (Kellgren-Lawrence Grade IV) and from patients with no radiological or arthroscopic evidence of OA. The distribution of the molecular weight of hyaluronan was measured using both gel electrophoresis and size-exclusion chromatography, and hyaluronan concentration was determined by immunosorbent assay and differential refractometry.
The distributions of molecular weight were highly variable within each group of patients; the average distributions, however, were identical in the 2 groups. The average concentration of hyaluronan also did not differ statistically between the 2 groups.
We found no evidence of hyaluronan degradation in synovial fluid of patients with OA. Commonly expressed opinion in the literature to the contrary may have resulted from a failure to adequately consider the limitations of previous experimental studies.
尽管文献中经常提到骨关节炎(OA)会导致透明质酸降解,但关于滑液中透明质酸成分的变化是否与 OA 相关,这一问题尚未得到实验验证。我们通过比较 OA 患者和无 OA 患者滑液中透明质酸的分子量和浓度来评估这一假设。
通过关节内穿刺抽吸获得 OA 晚期(Kellgren-Lawrence 分级 IV 级)患者和无放射学或关节镜 OA 证据患者的滑液。使用凝胶电泳和排阻色谱法测量透明质酸分子量的分布,通过免疫吸附测定和差示折射法测定透明质酸浓度。
两组患者的分子量分布均高度可变;然而,两组的平均分布相同。两组间透明质酸浓度也无统计学差异。
我们在 OA 患者的滑液中未发现透明质酸降解的证据。文献中普遍存在的相反观点可能是由于未能充分考虑之前实验研究的局限性所致。